
Vanderbilt Report · Pharma Desk · June 23, 2026

Pharmaceutical News: A Big Month of FDA Decisions and New

Vanderbilt Report · Weekly Pharma Briefing · Week of June

A Pancreatic Cancer Breakthrough, Lilly’s $25B Deal Spree, and

Executive Summary Jaguar Health, Inc. (NASDAQ: JAGX) represents a unique

The pharmaceutical industry in 2025 is at a dynamic crossroads,
